Literature DB >> 15047668

Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease.

Harrihar A Pershadsingh, Theodore W Kurtz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047668     DOI: 10.2337/diacare.27.4.1015

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  20 in total

1.  The metabolic effects of angiotensin-receptor blockers.

Authors:  Michael L Tuck; Dalila B Corry
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

2.  The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients.

Authors:  R Negro; G Formoso; H Hassan
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

3.  Angiotensin Receptor Blockers for the Prevention of Atrial Fibrillation Recurrences: Unending Hot Debate.

Authors:  Turgay Celik
Journal:  J Atr Fibrillation       Date:  2010-10-22

Review 4.  PPAR ligands: potential therapies for metabolic syndrome.

Authors:  Taro E Akiyama; Peter T Meinke; Joel P Berger
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

5.  Metabolic effects of telmisartan in spontaneously hypertensive rats.

Authors:  Yong-Qi Li; Hui Ji; Yi-Hua Zhang; Da-Yong Ding; Xiao-Lei Ye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-20       Impact factor: 3.000

Review 6.  Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Authors:  André J Scheen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Angiotensin-receptor blocking agents and the peroxisome proliferator-activated receptor-gamma system.

Authors:  Michael L Tuck
Journal:  Curr Hypertens Rep       Date:  2005-08       Impact factor: 5.369

Review 8.  New standards in hypertension and cardiovascular risk management: focus on telmisartan.

Authors:  Domenico Galzerano; Cristina Capogrosso; Sara Di Michele; Antonio Galzerano; Paola Paparello; Diana Lama; Carlo Gaudio
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

9.  Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series.

Authors:  Mojca Jensterle; Andrej Janez; Bojan Vrtovec; Helena Meden-Vrtovec; Marija Pfeifer; Janez Prezelj; Tomaz Kocjan
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

10.  The effects of simultaneous administration of dietary conjugated linoleic acid and telmisartan on cardiovascular risks in rats.

Authors:  Mohammad M Abdullah; Zuyuan Xu; Grant N Pierce; Mohammed H Moghadasian
Journal:  Lipids       Date:  2007-08-07       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.